Gene Query: SSB

Dataset Description Geneva Score
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 55.31
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 40.47
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 36.46
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 34.89
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 32.87
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 31.57
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 30.42
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 26.43
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 25.71
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 24.79
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 24.72
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 24.36
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 24.06
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 23.84
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 23.8
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 23.8
Determination of tRNA aminoacylation levels by high throughput sequencing 23.35
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 23.06
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 22.73
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 22.7
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 22.7
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 22.18
Cleavage Factor Im as a key regulator of 3’ UTR length 21.21
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 21.14
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 20.79
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 20.39
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 20.14
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 20.14
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 19.93
RNA-Seq of PRMT1 overexpression ECA109 cells 19.61
Co-transcriptional loading of RNA export factors shapes the human transcriptome 19.57
RNAseq of HEK293 cells after Chtop knockdown 19.57
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 19.36
Single-nucleotide-resolution mapping of HBV promoters using CAGE 19.35
Effects of rFVIIIFc on human macrophages 19.09
Macrophage Ad5f35 M2 Challenge 18.96
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 18.76
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 18.59
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 18.44
Hepatitis C virus functionally sequesters miR-122 18.44
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 18.35
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 18.17
Global Mapping of Human RNA-RNA Interactions 18.11
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 17.64
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 17.64
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 17.64
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 17.58
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 17.43
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 17.29
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 16.81
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 16.44
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 16.17
NRDE2 negatively regulates nuclear exosome functions 16.15
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 15.92
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 15.92
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 15.74
Transcriptomic analysis of the HOTAIR-regulated genes 15.68
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 15.6
Total RNA-seq in ALL-SIL upon TLX1 knockdown 15.4
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 15.36
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 15.31
TCF7L1 knockdown in pancreatic cancer 15.05
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 14.91
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 14.75
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 14.55
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 14.42
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 14.11
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 14.07
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 14.01
Global analysis of enhancer targets: Mosaic-seq 13.99
Human cell line and subcutaneous tumor 13.85
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 13.73
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 13.61
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 13.61
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 13.44
Differetially expressed genes after hTR overexpression in U2OS cells 13.23
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 13.13
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 13.06
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 13.02
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 13.01
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 12.97
Profiling of escape kinetics of viruses subjected to RNAi 12.96
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 12.89
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 12.81
Survival of pancreatic cancer cells lacking KRAS function 12.65
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 12.6
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 12.6
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 12.49
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 12.49
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 12.49
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 12.48
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 12.46
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 12.46
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 12.37
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 12.37
Efficient and quantitative high-throughput tRNA sequencing 12.36
RNA-seq melanoma 12.35
Differentiation enhances Zika virus infection in neuronal brain cells 12.29
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 12.26
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 12.23
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 12.19
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 12.15
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 12.0
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 12.0
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 11.92
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 11.92
3’ Uridylation Expands miRNA Target Repertoire 11.9
RNA sequencing of primary human platelets and in vitro cell lines 11.89
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 11.87
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 11.87
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 11.86
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 11.85
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 11.84
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 11.77
Genome-wide discovery of human splicing branchpoints [RNAse] 11.77
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 11.72
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 11.72
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 11.69
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 11.69
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 11.61
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 11.61
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 11.59
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 11.56
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 11.4
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 11.28
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 11.16
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 11.16
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 11.09
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 11.08
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 11.0
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 10.97
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 10.88
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 10.87
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 10.85
Differentially expressed vascular development genes for iPSC-ECs from CDI 10.81
The evolution of N6-methyladenosine in primates 10.75
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 10.7
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 10.68
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 10.67
A role for ZNF598 in post-transcriptional gene regulation 10.66
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 10.54
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 10.53
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 10.51
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 10.5
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 10.5
MEIS1 regulates hematopoiesis in hPSCs 10.43
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 10.4
Transcriptome of U251 cells overexpression complement component 7 10.24
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 10.21
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 10.19
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 10.14
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 10.14
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 10.12
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 10.12
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 10.04
Reassessment of Exosome Composition 10.03
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 10.01
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 10.0
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 9.93
Macrophage Ad5f35 PhenoMap 9.84
mRNA expression profile of Lymphocytes 9.83
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 9.83
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 9.83
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 9.73
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 9.67
HEK293 Heat-shock experiment 9.62
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 9.56
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 9.55
Identification of transcription start sites for human A549 cell line using ReCappable-seq 9.49
Molecular Criteria for Defining the Naive Human Pluripotent State 9.48
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 9.45
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 9.34
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 9.34
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 9.29
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 9.24
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 9.22
Role of cervicovaginal microbiota in genital inflammation 9.15
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 9.12
CROP-Seq in Primary Human T Cells 9.12
Transcriptional profiling of microglia; current state of the art and future perspectives 9.1
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 9.08
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 9.06
Global analysis of alternative splicing regulated by RBM10 9.04
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 8.96
Genome wide expression change by RNF168 knocking down in NEC cells 8.93
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 8.9
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 8.9
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 8.87
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 8.8
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 8.75
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 8.71
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 8.7
FOXD3 is a novel tumor suppressor in lung cancer 8.66
RNA sequencing of GlyH-101-treated MCF-7 cell line 8.6
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 8.58
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 8.56
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 8.53
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 8.53
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 8.5
Transcriptomic analyssis following EHMT1/2 inhibition 8.34
Hepatocyte maturation 8.31
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 8.28
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 8.28
Identifying the molecular mode of action of itraconazole in colorectal cancer 8.22
Novel Targeting of Transcription and Metabolism in Glioblastoma 8.22
Triple vectors expand AAV transfer capacity in the retina 8.2
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 8.17
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 8.17
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 8.15
Genome-wide discovery of human splicing branchpoints 8.12
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 8.11
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 8.11
MicroRNA-125a-5p overexpression in human macrophages 8.1
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 8.08
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 8.07
RNA transcriptome analysis during HSV-1 infection 7.97
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 7.88
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 7.82
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 7.76
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 7.76
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 7.73
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 7.71
Systematic discovery of endogenous human ribonucleoprotein complexes 7.7
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 7.7
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 7.7
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 7.49
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 7.49
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 7.43
In vitro modeling of human germ cell development using pluripotent stem cells 7.42
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 7.41
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 7.3
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 7.3
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 7.29
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 7.22
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 7.21
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 7.21
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 7.2
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 7.17
Integrating single-cell transcriptomic data across different conditions, technologies, and species 7.16
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 7.15
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 7.15
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 7.11
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 7.11
STX4 Over-Expression in Human islets 7.11
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 7.1
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 7.1
Global analyses of the effect of different cellular contexts on microRNA targeting 7.07
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 7.07
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 7.04
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 7.04
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 7.03
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 6.99
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 6.99
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 6.96
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 6.95
EP400 is required for Max and MCPyV mediated gene activation 6.93
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 6.92
RNA-seq of naive and primed ES cells 6.83
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 6.77
Sensing self and nonself circular RNAs 6.71
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 6.63
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 6.56
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 6.55
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 6.55
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 6.54
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 6.51
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 6.51
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 6.49
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 6.48
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 6.46
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 6.4
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 6.4
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 6.33
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 6.32
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 6.27
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 6.18
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 6.17
mRNA recovered upon RNF219 IP. [RNA-IP] 6.13
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 6.11
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 6.11
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 6.08
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 6.08
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 6.02
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 6.0
Effect of PRDM11 depletion in U2932 cells 5.96
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 5.86
METTL3 and WTAP 5.84
BCL11B 5.8
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 5.71
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 5.63
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 5.6
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 5.57
Ro60-knockout cells 5.54
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 5.54
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 5.54
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 5.54
RNA-seq of RKO cells with cTAZ KO or putback 5.46
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 5.4
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 5.37
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 5.37
m6A-dependent regulation of messenger RNA stability 5.34
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 5.33
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 5.33
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 5.28
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 5.24
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 5.21
NAPRT activation of macrophages 5.13
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 5.09
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 5.02
Proteomics identifies a marker signature of MAPKi resistance in melanoma 5.02
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 5.0
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 4.99
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 4.96
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 4.8
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 4.78
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 4.73
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 4.71
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 4.71
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 4.69
Identification of miRNA signatures during the differentiation of hESCs into retinal pigment epithelial cells 4.69
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 4.62
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 4.61
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 4.59
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 4.57
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 4.56
Effect of BB608 on Gene Expression in HNSCC Cell Line 4.55
Gene expression profiling in metabolically heterogeneous human lung tumors 4.53
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 4.4
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 4.4
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 4.39
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 4.37
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 4.36
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 4.29
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 4.28
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 4.2
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 4.15
Transcriptomic profile of human embryonic renal corpuscles 4.13
Transcriptional responses of melanoma cells to BRAF inhibition 4.13
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 4.1
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 4.1
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 4.08
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 4.06
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 4.06
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 4.01
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 3.91
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 3.9
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 3.9
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 3.9
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 3.89
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 3.89
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 3.88
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 3.86
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 3.82
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 3.78
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 3.75
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 3.67
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 3.67
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 3.62
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 3.62
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 3.57
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 3.56
Ribosome profiling upon inhibition of eIF4A 3.53
Gene expression regulated by CSA and CSB in neuroblastoma cell line 3.53
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 3.46
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 3.43
Transposon-based construction of strand-specific RNA-seq libraries 3.4
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 3.38
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 3.38
TOP2B disturbed the quality of human oocytes with advanced maternal age 3.36
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 3.33
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 3.32
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 3.32
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 3.31
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 3.27
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 3.22
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 3.18
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 3.18
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 3.16
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 3.15
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 3.13
Human Airway Smooth Muscle Transcriptome Changes in Response to Asthma Medications 3.07
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 3.03
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 3.01
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 2.99
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 2.97
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 2.96
Real-time observation of light-controlled transcription in living cells 2.94
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 2.93
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 2.9
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 2.89
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 2.87
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 2.85
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 2.82
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 2.82
Determining mRNA half-lives on a transcriptome-wide scale 2.77
Regulation of hypoxia-inducible factor activity by ZMYND8 2.76
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 2.66
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 2.65
FBXW7 modulates stress response by post-translational modification of HSF1 2.64
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 2.64
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 2.61
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 2.59
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 2.57
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 2.57
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 2.56
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 2.56
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 2.53
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 2.49
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 2.47
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 2.47
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 2.47
Measure transcript integrity using RNA-seq data 2.47
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 2.41
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 2.29
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 2.29
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 2.2
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 2.1
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 2.09
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 2.07
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 2.07
Regulatory network controlling tumor-promoting inflammation in human cancers 1.95
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 1.95
Exploring ILF2 regulatory genes by next-generation sequencing 1.88
Aneuploidy-induced cellular stresses limit autophagic degradation. 1.85
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 1.84
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 1.81
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 1.81
The contribution of Alu exons to the human proteome 1.74
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 1.74
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 1.74
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 1.74
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 1.7
Transcriptomes of oxLDL exposed trained monocytes 1.68
oxLDL exposed trained monocytes 1.68
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 1.64
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 1.64
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 1.61
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 1.59
Transcription elongation regulates genome 3D structure 1.55
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 1.5
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 1.47
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 1.47
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 1.47
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 1.46
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 1.39
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 1.38
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 1.38
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 1.38
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.31
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 1.29
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 1.23
WNT signaling memory is required for ACTIVIN to function as a morphogen 1.22
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 1.2
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 1.19
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 1.16
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 1.14
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 1.14
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 1.13
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 1.02
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 1.0
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 0.97
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 0.96
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 0.93
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 0.91
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 0.91
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.87
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.85
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 0.84
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 0.8
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 0.72
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 0.7
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.66
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 0.63
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 0.57
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 0.57
Genome-wide mapping of TEL-AML1 targets in acute leukemia 0.56
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 0.5
RNA sequencing with KSHV infection and enrichment for circular RNAs 0.48
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 0.44
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 0.42
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.38
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 0.38
MARCKS and lnc-MARCKS act as inflammation regulators 0.36
A code of mono-phosphorylation modulates the function of RB. 0.35
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.34
An siRNA screen identifies CHD4 as a target for epigenetic therapy 0.27
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 0.26
EGR1-controlled transcriptome of T HESCs 0.26
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 0.25
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 0.22
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 0.22
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 0.17
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.17
Modulation of nonsense-mediated decay by rapamycin 0.17
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.12
Iron response of HepG2 cells 0.09
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.04
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 0.02
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.02
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation